Who is sponsoring NCT06616480?

NCT06616480 is sponsored by BenQ Materials Corporation.

What drugs are being tested in NCT06616480?

Interventions in NCT06616480: BenQ Materials DSFNC1 soft hydrophilic contact lenses, Visco SiHy Color soft hydrophilic contact lenses.

Is NCT06616480 still recruiting?

NCT06616480 is currently completed. Last updated 27 September 2024.

Last reviewed 2024-09-27 · How we verify

NCT06616480

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Study to Evaluate the Safety and Efficacy of DSFNC1 Soft Hydrophilic Contact Lenses and SiHy Color Soft Hydrophilic Contact Lenses

Completed NA Last updated 27 September 2024

What this trial tests

NA trial testing BenQ Materials DSFNC1 soft hydrophilic contact lenses in Myopia in 192 participants. Completed in 20 June 2024.

Timeline

3 March 2023

Primary endpoint
28 March 2024

20 June 2024

Quick facts

Lead sponsor	BenQ Materials Corporation
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	192
Start date	3 March 2023
Primary completion	28 March 2024
Estimated completion	20 June 2024
Sites	1 location across China

Drugs / interventions tested

BenQ Materials DSFNC1 soft hydrophilic contact lenses
Visco SiHy Color soft hydrophilic contact lenses

Conditions studied

Myopia — all drugs for Myopia →

Sponsor

BenQ Materials Corporation

Who can join

18 and older, any sex, with Myopia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This project is an open, parallel, randomly controlled, and non-inferiority clinical trial of DSFNC1 soft hydrophilic contact lenses with SiHy color soft hydrophilic contact lenses.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Myopia

Currently open trials in the same condition.

NCT07284966 — Comfort and Vision With TOTAL30 Multifocal Lenses · recruiting
NCT07078799 — Wavefront-guided LASIK Surgery Compared to Ray Tracing-Guided LASIK Surgery · NA · recruiting
NCT07585877 — Effect of Branched-Chain Amino Acid Supplementation on Myopia Progression · NA · active not recruiting
NCT07354945 — An Evaluation of Myopia Control Lenses on Wearing Experience in Myopic Children · NA · recruiting
NCT07229365 — Children's Viewing Behavior · NA · recruiting

Other BenQ Materials Corporation trials

Trials by the same sponsor.

NCT06616519 — A Study to Evaluate the Safety and Efficacy of MSENC1 Soft Hydrophilic Contact Lenses and Oxypure Color Soft Hydrophilic · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06616480 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by BenQ Materials Corporation
Last refreshed: 27 September 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06616480.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing